160 related articles for article (PubMed ID: 12561066)
21. Expression of bcl-2 and the progression of human and rodent prostatic cancers.
Furuya Y; Krajewski S; Epstein JI; Reed JC; Isaacs JT
Clin Cancer Res; 1996 Feb; 2(2):389-98. PubMed ID: 9816182
[TBL] [Abstract][Full Text] [Related]
22. [Expression of MIB-1/KI-67 and bcl-2 in gastric carcinoma. Relationship with clinico-pathological factors].
Sundblad AS; Tamayo R
Acta Gastroenterol Latinoam; 1995; 25(2):67-72. PubMed ID: 8525762
[TBL] [Abstract][Full Text] [Related]
23. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration.
Mayer B; Johnson JP; Leitl F; Jauch KW; Heiss MM; Schildberg FW; Birchmeier W; Funke I
Cancer Res; 1993 Apr; 53(7):1690-5. PubMed ID: 8453643
[TBL] [Abstract][Full Text] [Related]
24. Establishment and characterization of a human gastric carcinoma cell line that is highly metastatic to lymph nodes.
Yamaguchi K; Ura H; Yasoshima T; Shishido T; Denno R; Hirata K
J Exp Clin Cancer Res; 2000 Mar; 19(1):113-20. PubMed ID: 10840945
[TBL] [Abstract][Full Text] [Related]
25. Depth of infiltration of primary gastric B-cell lymphomas--correlations with proliferation, apoptosis and expression of p53 and bcl-2.
Eidt S; Lorenzen J; Ortmann M
Pathol Res Pract; 1996 Sep; 192(9):925-30. PubMed ID: 8950759
[TBL] [Abstract][Full Text] [Related]
26. Aberration of p53 and DCC in gastric and colorectal cancer.
Kataoka M; Okabayashi T; Johira H; Nakatani S; Nakashima A; Takeda A; Nishizaki M; Orita K; Tanaka N
Oncol Rep; 2000; 7(1):99-103. PubMed ID: 10601600
[TBL] [Abstract][Full Text] [Related]
27. Analysis of macroscopic appearance and p53 expression in superficial esophageal carcinoma.
Natsugoe S; Nakashima S; Kijima F; Shimada M; Kusano C; Yoshinaka H; Baba M; Takao S; Aikou T
Hepatogastroenterology; 1999; 46(28):2398-404. PubMed ID: 10522005
[TBL] [Abstract][Full Text] [Related]
28. [Correlation between laminin and fibronectin on the basement membrane and tumor progression in early gastric cancer: an immunohistochemical study].
Fujita J
Hokkaido Igaku Zasshi; 2000 Jan; 75(1):25-34. PubMed ID: 10736758
[TBL] [Abstract][Full Text] [Related]
29. MnSOD expression is increased in metastatic gastric cancer.
Malafa M; Margenthaler J; Webb B; Neitzel L; Christophersen M
J Surg Res; 2000 Feb; 88(2):130-4. PubMed ID: 10644478
[TBL] [Abstract][Full Text] [Related]
30. Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival.
Grogan TM; Fenoglio-Prieser C; Zeheb R; Bellamy W; Frutiger Y; Vela E; Stemmerman G; Macdonald J; Richter L; Gallegos A; Powis G
Hum Pathol; 2000 Apr; 31(4):475-81. PubMed ID: 10821495
[TBL] [Abstract][Full Text] [Related]
31. [Quantitative analysis of E-cadherin expression and clinicopathologic evaluation in gastric cancer].
Dai D; Chen J; Xu L
Zhonghua Yi Xue Za Zhi; 1997 Sep; 77(9):668-71. PubMed ID: 9772535
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy, Ki-67 and p53 as indicators of lymph node metastasis in early gastric carcinoma.
Sasaki O; Kido K; Nagahama S
Anal Quant Cytol Histol; 1999 Feb; 21(1):85-8. PubMed ID: 10068782
[TBL] [Abstract][Full Text] [Related]
33. Analysis of early gastric cancer cases collected from major hospitals and institutes in Japan.
Fukutomi H; Sakita T
Jpn J Clin Oncol; 1984 Jun; 14(2):169-79. PubMed ID: 6737707
[TBL] [Abstract][Full Text] [Related]
34. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer.
Xiangming C; Hokita S; Natsugoe S; Tanabe G; Baba M; Takao S; Kuroshima K; Aikou T
Oncology; 1999; 57(2):131-7. PubMed ID: 10461060
[TBL] [Abstract][Full Text] [Related]
35. [Study of the relationship between the expression of Ki-67 antigen and the pathobiological behaviours of stomach cancer].
Xin Y; Wu D; Zhao F
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):382-4. PubMed ID: 10920923
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis.
Masuda M; Takano Y; Iki M; Asakura T; Hashiba T; Noguchi S; Hosaka M
Pathol Int; 1998 Jan; 48(1):41-6. PubMed ID: 9589463
[TBL] [Abstract][Full Text] [Related]
37. Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependence.
Nikiforov MA; Kwek SS; Mehta R; Artwohl JE; Lowe SW; Gupta TD; Deichman GI; Gudkov AV
Oncogene; 1997 Dec; 15(25):3007-12. PubMed ID: 9444949
[TBL] [Abstract][Full Text] [Related]
38. [Superficial cancer of the stomach: evolution of their characteristics over a 20 year period in one population].
Benhamiche AM; Faivre J; Tazi MA; Darsouni R; Villing AL; Couillault C
Gastroenterol Clin Biol; 1998 Jan; 22(1):13-8. PubMed ID: 9762160
[TBL] [Abstract][Full Text] [Related]
39. [Adhesion molecules and cancer metastasis].
Shiozaki H; Mori T
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2361-8. PubMed ID: 1952955
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of p105 expression and malignancy in gastric cancers].
Yonemura Y; Oyama S; Kimura H; Kamata T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):118-21. PubMed ID: 1674814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
